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Introduction. Conflicting results have been reported about the true impact of intradiverticula ampulla (IA) on the technical success
and complication rate of endoscopic retrograde cholangiopancreatography (ERCP). Patients. A total of 500 patients who underwent
ERCP were divided into two groups according to the presence (group A, 81 patients) or absence (group B, 419 patients) of IA.
Success rate, difficulty at cannulation, findings at ERCP, and procedure-related complicationswere retrospectively reviewed.Results.
Successful cannulation was achieved in 100% of group A patients compared to 98% of group B patients (P = ns). There was a
significant difference in the type of cannulation that was routinary in group B (𝑃 < 0.05), while requiring guidewire in group A
(𝑃 < 0.05). Cholangitis (𝑃 < 0.05), microstones (𝑃 < 0.01), dilated common bile duct without stones (𝑃 < 0.01), stone recurrence
(𝑃 < 0.01), and transient postprocedure hyperamylasemia (𝑃 < 0.01) were more frequently observed in group A. There was no
significant difference in complication rate between both groups.Conclusions.The finding of an IA at ERCP should not be considered
a predictor for failed cannulation. IA is associated with post-ERCP transient hyperamylasemia and is a risk factor for biliary stone
disease and its recurrence.
1. Introduction
Intradiverticular ampulla (IA) or periampullary duodenal
diverticula (PDD) are found in 9% to 32% of patients
undergoing endoscopic retrograde cholangiopancreatogra-
phy (ERCP). One of the myths of operative biliary endoscopy
is that IA makes deep biliary cannulation difficult or even
impossible [1].
The aim of our study is to investigate the impact of PDD
on technical success and complications of an ERCP.
2. Materials and Methods
A total of 551 consecutive ERCPs were performed from
January 2008 to December 2012 at our surgical endoscopy
unit. Fifty-one patients were excluded from the study because
of prior endoscopic sphincterotomy (𝑛 = 12) or placement
of stent (𝑛 = 20) or undetectable papilla (𝑛 = 19) after a
thorough examination of the second duodenal portion. None
of the excluded patients had PDD. As a result, this study
includes 500 patients, who were divided into two groups
according to the presence or absence of PDD.There were 218
males and 282 females with a mean age of 59.2 years (range,
18 to 89 years). Indications for ERCP included gallstone
pancreatitis, common bile duct (CBD) stones, cholangitis,
neoplasms (CBD and pancreas), and pancreas divisum. Data
were collected from a prospectively maintained database.
All the procedures were performed by the same operator,
using Olympus TJF 145 side-view endoscopes. All patients
received a combination of midazolam and fentanyl, on esca-
lating dosing according to the needs for conscious sedation.
Supplemental oxygen was given transnasally during the
entire procedure. Biliary cannulation was attempted by using
a standard three-lumen sphincterotome after the intravenous
administration of hyoscine butylbromide 20mg.Cannulation
was considered successful when the sphincterotome was
inserted deeply into the CBD and a cholangiogram was
obtained. When biliary cannulation was not achieved by
standard sphincterotome, we used hydrophilic guidewire or
needle-knife precut papillotomy with or without a pancreatic
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Figure 1: Incidence of the different types of PDD according to the position of the major papilla (modified from [1]).
stent. Sphincterotomy was then completed with an endocut
mode. Difficulty at cannulation was graded as follows: grade
I, easy deep cannulation with routinary methods; grade
II, requirement of guidewire or special sphincterotome to
achieve cannulation; grade III, difficult cannulation that
requires special techniques and skills as needle-knife sphinc-
terotomy; grade IV, impossibility of deep cannulation [1].
IA related to major papilla was classified according to
Boix into the following: type I, papilla located inside the
diverticulum (Ia “up,” Ib “left,” Ic “down,” and Id “right”); type
II, papilla located in the margin of the diverticulum (IIa
“apical left margin,” IIb “apical right margin,” IIc “center left
or right margin,” and IId “between two diverticula”); type III,
papilla located near of the diverticulum [1].
Success rate, difficulty at cannulation, findings at ERCP,
and procedure-related complications in patients with IA
(group A) were compared to those of patients with normal
duodenum (group B). Demographic features as well as
indications for ERCP were also evaluated. Statistical analysis
was done by Student’s t-test for continuous variables and by
𝜒
2 test or Fisher’s exact test for discrete variables. A 𝑃 value
<0.05 was considered significant.
3. Results
IA was observed in 81 of 551 patients, accounting for a
prevalence rate of 14.7%. The papilla was undetectable at
ERCP in none of the patients with PDD compared to 19 of
470 patients (4.04%) without diverticula.
Mean age was significantly higher (𝑃 < 0.05) in group
A (69.5 years) than in group B (49.7 years). Demographic
and clinical features of the patients referred for ERCP are
compared in Table 1. Cholangitis was significantly more
common in group A (38.3%) than in group B (22.9%), while a
lower prevalence of pancreatic or CBD neoplasms was found
among patient with IA (9.9% versus 19.5%, 𝑃 < 0.05).
Table 1: Demographics and clinical presentation of the patients
referred for ERCP.
Group A
𝑛 = 81
Group B
𝑛 = 419
𝑃
Mean age (yrs) 69.5 49.7 <0.05
Range of age (yrs) 54–89 18–75 na
M/F ratio 36/45 182/237 na
Indications
Gallstone pancreatitis 30/81 (37%) 138/419 (32.9%) 0.51 (ns)
CBD stones 53/81 (65.4%) 257/419 (61.3%) 0.48 (ns)
Cholangitis 31/81 (38.3%) 96/419 (22.9%) <0.05
Neoplasms (CBD and
pancreas) 8/81 (9.9%) 82/419 (19.5%) <0.05
Pancreas divisum — 1/419 (0.2%) 0.85 (ns)
ns: not significative; na: not applicable; CBD: common bile duct.
Incidence of PDD is detailed in Figure 1. The most
common diverticula were type I (56%), followed by type II
(35%) and type III (9%).
The ampulla was detected in all patients with PDD. Deep
biliary cannulation was achieved in 100% of patients with
IA compared to 98% of patients without IA (𝑃 = ns). Easy
cannulation with standardmethods was achieved in 84.2% of
group B patients compared to 7.4% of group A (𝑃 < 0.05);
guidewire or special sphincterotome was required to achieve
cannulation in 88.9% of group A patients compared to 12.6%
of group B (𝑃 < 0.05). No statistically significant difference
in the use of needle-knife precut papillotomy with or without
a pancreatic stent was observed between both groups.
At ERCP, biliary sludge with microstones and dilated
CBD in absence of stones were more frequently discovered
in group A (𝑃 < 0.01), while pancreatic cancer and cholan-
giographic abnormalities were prevalent in group B (𝑃 <
0.01). Moreover, patients with IA had higher incidence of
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Table 2: ERCP results.
Group A
𝑛 = 81
Group B
𝑛 = 419
𝑃
Successful cannulation 81/81 (100%) 412/419 (98%) 0.2 (ns)
Difficult cannulation
(Boix scale)
Grade I 6/81 (7.4%) 353/419 (84.2%) <0.05
Grade II 72/81 (88.9%) 53/419 (12.6%) <0.05
Grade III 3/81 (3.7%) 6/419 (1.4%) 0.16 (ns)
Grade IV 0 7/419 (1.7%) 0.24 (ns)
CBD stones > 10mm 13/81 (16.1%) 61/419 (14.5%) 0.72 (ns)
Biliary sludge and
microstones 27/81 (33.3%) 68/419 (16.2%) <0.005
Ampulloma/ampullary
cancer 0 21/419 (5.0%) 0.07 (ns)
Biliary hilar cancer
(Klatskin) 3/81 (3.7%) 31/419 (7.4%) 0.22 (ns)
Pancreatic cancer 0 48/419 (11.4%) <0.005
Cholangiographic
abnormalities
(stones, strictures,
dilation)
51/81 (62.9%) 398/419 (95%) <0.005
Dilated CBD without
stones 30/81 (37.1%) 21/419 (5.0%) <0.005
Other (liver metastasis,
hemobilia) 2/81 (5.5%) 6/419 (1.4%) 0.49 (ns)
Complications
Clinical bleeding 1/81 (1.2%) 15/419 (3.6%) 0.27 (ns)
Perforation 0 2/419 (0.5%) 0.53 (ns)
Pancreatitis 2/81 (2.4%) 12/419 (2.9%) 0.84 (ns)
Cholecystitis 0 0 na
Death (ERCP related) 0 0 na
Immediate bleeding 1/81 (1.2%) 14/419 (3.3%) 0.31 (ns)
Hyperamylasemia 52/81 (64.2%) 106/419 (25.3%) <0.005
CBD stone recurrence at
followup 53/81 (65.4%) 38/419 (9.1%) <0.005
ns: not significative; na: not applicable; CBD: common bile duct.
postoperative transient hyperamylasemia as well as CBD
stones recurrence at 1-year followup (𝑃 < 0.01). Success rate,
difficulty at cannulation, ERCP findings, procedure-related
complications, and CBD stone recurrence are summarized in
Table 2.
4. Discussion
PDD (or IA) were first described by Chomel in 1710. They
are extraluminal outpouchings of the duodenum adjacent to
or containing the ampulla of Vater. PDD are true acquired
pulsion diverticula, which involve all layers of the duodenal
wall and occur because of abnormalmotility.They are usually
asymptomatic, but they can also be associatedwith significant
morbidity and, rarely, mortality [1, 2].
The true prevalence of PDD in the general population is
uncertain due to the diagnostic accuracy of various methods.
Prevalence rates on radiographic studies are as high as 5-6%,
while those at necroscopic investigations range from 5% to
19.4%. Prevalence rates from 4–9% to 25–32.8% have been
reported at esophagogastroduodenoscopy, the average being
from 10% to 20% [1, 3]. The higher rates reported at ERCP,
ranging from 6.8% to 54.9%, could be explained by a better
visualization of diverticula with lateral view duodenoscope
[3]. PDD are frequently discovered in elderly patients, and it
is generally accepted that their incidence increases with age
[1–4]. In our study, the prevalence of PDD was 16.2% and the
mean age of patients with diverticula was 69.5 years.
Panteris et al. found a significantly higher prevalence of
undetectable papilla in patients with PDD, probably related
to the possible location of the papilla inside a diverticulum
[3]. This was not confirmed in our study, where none of the
patients with diverticulum had undetectable papilla.
Most of the studies conducted to evaluate the impact of
PDD on technical issues as well as difficulty and potential
complications of an ERCP are inconclusive as to whether
diverticula are really only a benign bystander or a threat to
successful, easy, and safe cannulation and sphincterotomy [3].
Although successful cannulation rate in patients with PDD
ranges from 61% to 95.4%, this was found to be significantly
lower compared to that of patients without PDD in 4 of
7 studies reported in the literature [4–7]. In the remaining
3 studies [1, 8, 9], no statistically significant difference was
observed. Likewise, difficulty at cannulation was addressed
in 3 studies [1, 6, 7]: in 2 of them [6, 7], the results were
significantly toward a more difficult cannulation in patients
with diverticula, whereas no difference was found in the
third study [1]. Difficulty was assessed by the duration (>15
minutes) until cannulation [6], the number of attempts (>10)
for cannulation, or the method used to achieve cannulation
[1].
The presence of PDD is thought to make ERCP a tech-
nically demanding procedure, with relatively low success
rates. However, this belief is based on results from older
studies [2]. Cannulation of papilla situated deep in the large
diverticula can be difficult and time consuming and requires
more expertise [10]. In our experience, the presence of PDD
did not compromise the success rate, although it required the
use of guidewire to achieve cannulation (grade II difficulty
according to Boix) in most cases. Traditional landmarks for
performing sphincterotomy in this setting could be obscured
when the papilla is located at the edge of the diverticulum and
the biliary intraduodenal portion is not visible. In this case,
sphincterotomy should be performed over a guidewire, with
only few millimeters of the cutting wire inside the papilla;
directing the cut toward the base of the diverticulum should
be strictly avoided. Conversely, when the papilla is located
in the middle of a diverticulum, the intraduodenal portion
is outlined and the landmarks are usually more obvious than
in normal anatomy [11].
Association between PDD and ERCP-related complica-
tions, as bleeding and duodenal perforation, is controversial
[1, 3, 6, 10].This study supports themajority of published data
that PDD do not increase the risk for such complications.
Only transient hyperamylasemia without clinical significance
had a higher incidence among patients with diverticula.
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Perforation and bleeding were even less common in this
group.
Relationship between PDD and symptoms or clinical
findings is not clear [1]. The only scientific evidence, dated
back to 1980, is that PDD dispose primarily to gallstone
disease [6, 9, 12–14], because of an ascending infection
with glucuronidase producing bacteria, related to biliary
stasis [15, 16]; Escherichia coli, Streptococcus faecalis, Proteus
and Klebsiella spp., and anaerobes are the most common
organisms isolated [2]. In our series, biliary sludge and
microstones were more frequent in patients with diverticula
but not CBD stone >10mm. Moreover, 37.1% of patients
with PDD had dilated CBD in absence of stones. In such
cases, biliary symptoms could be related to the presence
of diverticula, with subsequent biliary stasis and bile duct
dilation on US or MRI [3]; in group B, 5% of patients had
CBD dilated without stones at ERCP; they were affected by
sphincter of Oddi dysfunction or papillodditis, presenting as
gallstones pancreatitis or cholangitis.
Finally, in this study a higher CBD stone recurrence was
associated with PDD. This can be explained by the decision
of the endoscopist to perform small sphincterotomies, espe-
cially when the papilla was in an awkward position with
respect to the diverticulum, for fear of causing a perforation
[3].
5. Conclusions
IA is not an uncommon incidental finding in Sicilian adult
patients undergoing ERCP. In our experience, the presence
of diverticula does not either affect the success rate of
ERCP or the incidence of procedure-related complications.
Cannulation can be achieved by using a guidewire in most
cases. PDD represent a risk factor for choledocholithiasis and
its recurrence.
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